LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
117,000
+6,200 (5.60%)
Jun 27, 2025, 3:30 PM KST
61.38%
Market Cap 4.24T
Revenue (ttm) 146.42B
Net Income (ttm) 24.86B
Shares Out 36.25M
EPS (ttm) 671.86
PE Ratio 174.14
Forward PE 78.95
Dividend n/a
Ex-Dividend Date n/a
Volume 795,730
Average Volume 370,058
Open 111,300
Previous Close 110,800
Day's Range 109,900 - 119,600
52-Week Range 66,900 - 143,600
Beta 0.79
RSI 59.16
Earnings Date Aug 14, 2025

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.